Clarifying the GOLD 2026 guidance for initial pharmacological COPD treatment

Alvar Agustí, David M.G. Halpin, Bart Celli, Claus F. Vogelmeier

Open source

DOI: 10.1183/13993003.00549-2026
Published: 2026-07
Container: European Respiratory Journal
Publisher: European Respiratory Society (ERS)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1183/13993003.00549-2026,
  title = {Clarifying the GOLD 2026 guidance for initial pharmacological COPD treatment},
  author = {Alvar Agustí and David M.G. Halpin and Bart Celli and Claus F. Vogelmeier},
  year = {2026},
  journal = {European Respiratory Journal},
  doi = {10.1183/13993003.00549-2026},
  url = {https://doi.org/10.1183/13993003.00549-2026}
}

RIS

TY  - JOUR
TI  - Clarifying the GOLD 2026 guidance for initial pharmacological COPD treatment
AU  - Alvar Agustí
AU  - David M.G. Halpin
AU  - Bart Celli
AU  - Claus F. Vogelmeier
PY  - 2026
JO  - European Respiratory Journal
DO  - 10.1183/13993003.00549-2026
UR  - https://doi.org/10.1183/13993003.00549-2026
ER  -

APA

Agustí, A., Halpin, D. M., Celli, B., & Vogelmeier, C. F. (2026). Clarifying the GOLD 2026 guidance for initial pharmacological COPD treatment. European Respiratory Journal. https://doi.org/10.1183/13993003.00549-2026

Source records

crossref · retrieved 2026-09-26T05:02:34.951Z